标题
Identification of a novel immune prognostic model in gastric cancer
作者
关键词
-
出版物
Clinical & Translational Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-28
DOI
10.1007/s12094-020-02478-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
- (2020) Kirsty Ford et al. CANCER RESEARCH
- IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
- (2020) Xiaoshun Shi et al. Journal of Translational Medicine
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody
- (2020) Hirofumi Ohmura et al. BRITISH JOURNAL OF CANCER
- Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
- (2020) Lucas A Horn et al. Journal for ImmunoTherapy of Cancer
- Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
- (2019) Sen Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
- (2019) Junyu Long et al. EBioMedicine
- CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
- (2019) Deepak Mittal et al. Cancer Immunology Research
- Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
- (2019) Yung-Jue Bang et al. Gastric Cancer
- Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
- (2019) Edo Kon et al. DRUG RESISTANCE UPDATES
- IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
- (2019) Moritz F. Eissmann et al. Nature Communications
- Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
- (2019) Crescenzo D’Alterio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
- (2019) Li-Tzong Chen et al. Gastric Cancer
- Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer
- (2019) Wei Li et al. Cell Death & Disease
- NOX4-driven ROS formation regulates proliferation and apoptosis of gastric cancer cells through the GLI1 pathway
- (2018) Chao-Tao Tang et al. CELLULAR SIGNALLING
- CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer
- (2018) Yuxin Yang et al. Cancer Medicine
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunotherapy in advanced gastric cancer, is it the future?
- (2018) C. Coutzac et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Increased tumor-infiltrating CD45RA−CCR7− regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress
- (2017) Fang-yuan Mao et al. Cell Death & Disease
- Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer
- (2017) Liu-sheng Peng et al. Cancer Immunology Research
- Gastric adenocarcinoma
- (2017) Jaffer A. Ajani et al. Nature Reviews Disease Primers
- Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination
- (2015) Takahisa Yamaguchi et al. Gastric Cancer
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages
- (2014) Wenyan Wang et al. Cellular & Molecular Immunology
- Treg functional stability and its responsiveness to the microenvironment
- (2014) Joseph Barbi et al. IMMUNOLOGICAL REVIEWS
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer – Differential treatment strategies for subtypes of early gastroesophageal cancer
- (2012) Manfred P. Lutz et al. EUROPEAN JOURNAL OF CANCER
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started